Ocular Therapeutix (OCUL) Global CCO files Form 3 showing no stock ownership

Rhea-AI Filing Summary

Ocular Therapeutix, Inc. officer David Wayne Robinson, who serves as Global Chief Commercial Officer, filed an initial ownership report on Form 3. The filing states that he currently has no securities beneficially owned in Ocular Therapeutix, meaning he reports no direct or indirect holdings of the company’s stock or derivative securities at this time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 01/26/2026 - 07:14 PM Learn about SEC filing dates

FAQ

Who is the reporting person in the OCUL Form 3 filing?

The reporting person is David Wayne Robinson, who serves as Global Chief Commercial Officer of Ocular Therapeutix, Inc.

What does the Ocular Therapeutix (OCUL) Form 3 disclose about insider ownership?

The Form 3 states that no securities are beneficially owned by Global Chief Commercial Officer David Wayne Robinson at the time of the report.

Is the reporting person a director or 10% owner of OCUL?

According to the filing, David Wayne Robinson is reported as an officer (Global CCO) and is not listed as a director or 10% owner of Ocular Therapeutix.

Are there any derivative securities reported in this OCUL Form 3?

No. The filing’s tables for both non-derivative and derivative securities report that no securities are beneficially owned.

Who signed the Form 3 for the Ocular Therapeutix officer?

The Form 3 was signed by Todd Anderman as Attorney-in-Fact for David Wayne Robinson, under a power of attorney referenced as Exhibit 24.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Robinson David Wayne

(Last) (First) (Middle)

C/O OCULAR THERAPEUTIX, INC.

15 CROSBY DRIVE

(Street)

BEDFORD MA 01730

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/21/2026

3. Issuer Name and Ticker or Trading Symbol
OCULAR THERAPEUTIX, INC [ OCUL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global CCO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit Index. Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Todd Anderman, Attorney-in-Fact for David Wayne Robinson	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.